Tserakson

Tserakson – the synthetic nootropic medicine applied at treatment of craniocereberal injuries and strokes.

Pharmacological action of Tserakson

Active component of Tserakson (цитиколин) has nootropic effect and, possessing a broad spectrum of activity:

• Promotes recovery of membranes of the cells which underwent damage;
• Improves cholinergic transfer in brain tissues;
• Reduces expressiveness of neurologic symptoms and duration of a posttraumatic coma at craniocereberal injuries;
• Interferes with education of free radicals;
• Inhibits action of phospholipases;
• Reduces brain tissue defeat volume in the acute period of a stroke.

Also Tserakson's use according to indications is effective at therapy of motive and sensitive neurologic disturbances of a vascular and degenerative etiology.

At a chronic hypoxia of a brain Tserakson, according to the instruction, is effective at treatment of many cognitive frustration, including:

• Difficulties when performing the simple actions connected with self-service;
• Lack of initiative;
• Memory impairment.

Besides, the medicine against the background of a disease reduces display of amnesia and increases the level of attention and consciousness.

Form of release of Tserakson

Tserakson release in a look:

• Pink solution for the intake containing in 100 ml 10 g of active component of a tsitikolin. In bottles on 30 ml;
• The colourless solution for injections containing 500 mg and 1 g of active component of a tsitikolin in 1 ampoule. In ampoules on 4 ml;
• The oblong white tablets containing 500 mg of active component of a tsitikolin. In packaging on 20 pieces.

Tserakson's analogs

Tserakson's analogs on the mechanism of action are medicines in various dosage forms:

• Solution for injections – Amilonosar, Lutsetam, Tserebrolizat, Tserebrolizin, Eskotropil;
• Tablets – Amilonosar, Acephen, Vero-Vinpotsetin, Vinpotsetin, Vintsetin, Ginos, Gopantam, Cavintonum, Lutsetam, Memoplant, Pantogamum, Memotropil, Noopept, Omaron;
• Capsules – Bilobil, Vinpotropil, Nootropil, Fezam;
• Concentrate for preparation of solution for infusions – Bravinton, Vinpotsetin;
• Raw materials vegetable – the Ginkgo bilobed leaves;
• Capsules – Ginkoum, Noben, Idebenon, Karnitsetin, Neyromet, Piracetam;
• Tablets hypoglossal – Glitsin;
• Solution for intake – Nooklerin, Tanakanum, Demanol, Kogitum, Nootropil;
• Extract dry – Korteksin;
• Drops nasal – Minithis Semaks.

Indications to Tserakson's use

According to the instruction, Tserakson appoint separately or as a part of complex therapy at treatment:

• Craniocereberal injuries (during the acute and recovery periods);
• Ischemic and hemorrhagic strokes (during the recovery period);
• Acute period of an ischemic stroke;
• The cognitive and behavioural disturbances caused by degenerative and vascular diseases of a brain.

Contraindications

Tserakson it is contraindicated to apply against the background of the expressed vagotonia, hypersensitivity to medicine components, and also in pediatrics up to 18 years.

The question of a possibility of use according to Tserakson's testimonies at pregnancy and in the period of a lactation should be solved individually with the doctor as there are no reliable data about efficiency and safety of a medicine during these periods.

Tserakson route of administration

Tserakson in the form of solution for intake it is possible to accept irrespective of meal, previously having parted it in a small amount of water (no more half-glass).

The recommended dose at use in the acute period of an ischemic stroke and craniocereberal injury makes 1 g twice a day. Therapy duration – is not less than six weeks.

During the recovery period of hemorrhagic and ischemic strokes, a craniocereberal injury, and also at the cognitive and behavioural disturbances arising at vascular and degenerative diseases of a brain, Tserakson's solution is accepted on 5-10 ml to two times a day. Duration of treatment is defined by the doctor individually.

Intravenously Tserakson's solution is entered in the form of a slow injection or kapelno in doses:

• In the acute period of a craniocereberal injury and ischemic stroke – 1 g twice a day for 6 weeks. In cases if function of swallowing is not broken, in 5 days since the beginning of therapy solution can be replaced with solution for intake or tablets Tserakson;
• During the recovery period of hemorrhagic and ischemic strokes and at the cognitive and behavioural disturbances caused by vascular and degenerative diseases of a brain, the recommended dose makes 5-10 ml 1-2 times a day.

The daily dose of Tserakson in tablets depending on disease severity makes 500 - 2000 mg for 1,5-2 months.

At advanced age at Tserakson's use in tablets or in the form of solution correction of a dose is not required.

Data on overdose by Tserakson are not presented in the instruction.

Medicinal interaction

At Tserakson's use according to indications it is necessary to consider that he increases effects of a levodopa.

According to the instruction, Tserakson it is not necessary to appoint together with the drugs containing Meclofenoxatum.

Side effects of Tserakson

According to reviews, Tserakson causes side effects in rare instances. At Tserakson's use, according to reviews, distinguish from frustration of a nervous system:

• Sleeplessness;
• Headache;
• Tremor;
• Excitement;
• Dizziness;
• Hallucinations;
• Numbness in the paralyzed extremities.

Also Tserakson, according to reviews, can cause:

• Acute anaphylaxis;
• Hypostases;
• Feeling of heat;
• Nausea;
• Asthma;
• Skin itch;
• Short-term change of arterial pressure;
• Vomiting;
• Rash;
• Diarrhea.

Storage conditions

Tserakson is among nootropic medicines of a prescription issue with a period of validity 3 years at observance of standard storage conditions.